Brief: Synlab Launches Revolutionary Bipolar Disorder Diagnostic Test Myedit-B

Synlab AG

10/10/2023 07:52

Oct 10 (Reuters) - SYNLAB AG  SYAB.DE :
    * LAUNCHES REVOLUTIONARY BIPOLAR DISORDER DIAGNOSTIC TEST:
MYEDIT-B
    * SYNLAB'S MYEDIT-B IS WORLD'S FIRST BLOOD-BASED TEST FOR
DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND UNIPOLAR
DEPRESSION
    * MYEDIT-B ALLOWS DIAGNOSIS OF BIPOLAR DISORDER WITHIN 24
DAYS,
IMPROVING PROSPECTS FOR PATIENTS SIGNIFICANTLY BY EXPEDITING
PROCESS OF IDENTIFYING DISEASE
    * INVOLVED IN WHOLE VALUE CHAIN DEVELOPMENT OF MYEDIT-B WITH
DIAGNOSTICS MANUFACTURER ALCEDIAG, WITHIN FRAMEWORK OF EU
FUNDING PROGRAMME EITHEALTH

Further company coverage:  SYAB.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))